SCHEDULE: Lowenstein Sandler Discloses 7.2% Stake in Cyabra

Lowenstein Sandler LLP has reported a 7.2% beneficial ownership stake in Cyabra, Inc., holding 1,000,000 shares of common stock.

Summary

• Lowenstein Sandler LLP, a New Jersey limited liability partnership, has filed a Schedule 13G.
• The filing reports beneficial ownership of 1,000,000 shares of Common Stock in Cyabra, Inc.
• This represents approximately 7.2% of Cyabra, Inc.'s outstanding Common Stock.
• The ownership percentage is based on 13,814,167 shares of Common Stock issued and outstanding as of March 27, 2026.
• Lowenstein Sandler LLP holds sole voting power and sole dispositive power over all 1,000,000 shares.
• The securities were not acquired for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as the disclosure of a significant passive stake by an institutional investor can signal confidence in the company, although it provides no operational or financial performance details.

Positives

• A significant institutional investor, Lowenstein Sandler LLP, has disclosed a 7.2% passive stake in Cyabra, Inc., potentially signaling confidence in the company.

Future Outlook

The Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Cyabra, Inc.'s future outlook.

Industry Context

StockSavvy.ai notes that the disclosure of a significant passive stake by an institutional entity like Lowenstein Sandler LLP can sometimes be interpreted by the market as a vote of confidence or an indication of underlying value, potentially attracting further investor interest in Cyabra, Inc. This type of filing is a standard regulatory requirement for investors acquiring more than 5% of a company's stock without intending to influence control.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership stakes and potential validation of the company's value by an institutional investor.

Key Dates

Keywords

Cyabra Inc, Lowenstein Sandler LLP, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, 23249H105